A novel circular RNA, hsa_circ_0043278, acts as a potential biomarker and promotes non-small cell lung cancer cell proliferation and migration by regulating miR-520f
Source abstract
Abstract
More and more circular RNAs (circRNAs) revealed to play a critical role in the initiation and progression of cancer, however, the effects of circRNAs on non-small cell lung cancer (NSCLC) remain largely undetermined. In the present study, we screened the dysregulated circRNAs in paired NSCLC and normal samples from GEO database and identified circ_0043278 was to be significantly up-regulated in NSCLC and demonstrated it promotes NSCLC progression in vitro and in vivo. Then, we revealed the expression of miR-520f, a downstream factor of circ_0043278, was significantly down-regulated in NSCLC and acted as a tumor inhibitor. In addition, we revealed that circ_0043278 sponged miR-520f, which was demonstrated to target ROCK1, CDKN1B, and AKT3 in NSCLC cells. In conclusion, circ_0043278 promoted NSCLC cell proliferation, invasion, and migration by increasing ROCK1, CDKN1B, and AKT3 expressions through direct inhibition of miR-520f.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Circular RNAs in diseases · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Respiratory Medicine, Suzhou Municipal Hospital, Suzhou Hospital Affiliated to Nanjing Medical University
Funding
Project of Suzhou Medical Key Discipline
References (28)
Show source-provided references
1. Qin H, Wang F, Liu H, et al. New advances in immunotherapy for non-small cell lung cancer. Am J Transl Res. 2018;10:2234–2245.
2. Szejniuk WM, Robles AI, McCulloch T, et al. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J. 2019;19(1):5–14.
3. 10.1155/2018/698494810.1155/2018/6984948 ↗
4. 10.2217/imt-2017-012110.2217/imt-2017-0121 ↗
5. 10.3390/cells711021210.3390/cells7110212 ↗
6. 10.1152/physrev.00041.201510.1152/physrev.00041.2015 ↗
7. 10.1042/BST2016008910.1042/BST20160089 ↗
8. 10.1042/BCJ2017007910.1042/BCJ20170079 ↗
9. 10.1016/j.gpb.2016.03.00710.1016/j.gpb.2016.03.007 ↗
10. 10.18632/oncotarget.1637510.18632/oncotarget.16375 ↗
11. 10.1016/j.canlet.2015.06.00310.1016/j.canlet.2015.06.003 ↗
12. 10.1371/journal.pone.009085910.1371/journal.pone.0090859 ↗
13. 10.1186/s13046-018-0870-810.1186/s13046-018-0870-8 ↗
14. 10.1159/00049254310.1159/000492543 ↗
15. 10.1016/j.semcancer.2017.11.01910.1016/j.semcancer.2017.11.019 ↗
16. Zhou Q, Huang SX, Zhang F, et al. MicroRNAs: a novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Cell Prolif 2017;50(6):e12394.10.1111/cpr.12394 ↗
17. 10.1186/s12943-017-0663-210.1186/s12943-017-0663-2 ↗
18. 10.1016/j.molcel.2014.08.01910.1016/j.molcel.2014.08.019 ↗
19. 10.1002/cam4.105510.1002/cam4.1055 ↗
20. Haque S, Harries LW. Circular RNAs (circRNAs) in health and disease. Genes (Basel). 2017;8(12):353.10.3390/genes8120353 ↗
21. 10.1007/s00592-016-0943-010.1007/s00592-016-0943-0 ↗
22. Yan B, Zhang W, Mao XW, et al. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2018;22:8712–8721.
23. 10.1002/cam4.151410.1002/cam4.1514 ↗
24. Qu D, Yan B, Xin R, et al. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 2018;8:1387–1402.
25. Tian X, Zhang L, Jiao Y, et al. CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis. J Cell Biochem. 2019:120(3):3765–3772.
26. 10.1016/j.gene.2018.03.00310.1016/j.gene.2018.03.003 ↗
27. 10.1007/s12041-018-1028-310.1007/s12041-018-1028-3 ↗
28. 10.4149/neo_2016_60610.4149/neo_2016_606 ↗